French Glendon E. III

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
25 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
French Glendon E. III's trades of Pulmonx Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
US Pulmonx Corp (LUNG)
S Sale
61,400 +25.3%
298.94
US$4,396,768 		61,400 +25.3% 298.94 US$4,396,768
2026-06-03 2026-06-01
US Pulmonx Corp (LUNG)
S Sale
83,785 +7.7%
307.60
US$267,919 		83,785 +7.7% 307.60 US$267,919
2026-06-03 2026-06-01
US Pulmonx Corp (LUNG)
S Sale
13,107 -25.4%
440.86
US$2,029,401 		13,107 -25.4% 440.86 US$2,029,401
2026-03-04 2026-03-02
US Pulmonx Corp (LUNG)
S Sale
58,368 -4.0%
1.43
US$83,466 		58,368 -4.0% 1.43 US$83,466
2026-03-04 2026-03-02
US Pulmonx Corp (LUNG)
S Sale
6,737 -0.5%
1.43
US$9,634 		6,737 -0.5% 1.43 US$9,634
2026-03-04 2026-03-02
US Pulmonx Corp (LUNG)
S Sale
2,708 -0.2%
1.43
US$3,872 		2,708 -0.2% 1.43 US$3,872
2025-12-03 2025-12-01
US Pulmonx Corp (LUNG)
S Sale
6,281 -2.2%
1.57
US$9,861 		6,281 -2.2% 1.57 US$9,861
2025-12-03 2025-12-01
US Pulmonx Corp (LUNG)
S Sale
2,524 -0.9%
1.57
US$3,963 		2,524 -0.9% 1.57 US$3,963
2025-03-21 2025-03-20
US Pulmonx Corp (LUNG)
PlS Planned sale
20,000 -2.0%
7.85
US$157,000 		20,000 -2.0% 7.85 US$157,000
2025-03-20 2025-03-20
US Pulmonx Corp (LUNG)
PrS Proposed sale
60,000
7.77
US$466,200 		60,000 7.77 US$466,200
2025-02-24 2025-02-20
US Pulmonx Corp (LUNG)
PlS Planned sale
12,417 -1.2%
8.76
US$108,773 		12,417 -1.2% 8.76 US$108,773
2025-02-24 2025-02-20
US Pulmonx Corp (LUNG)
PlS Planned sale
43,036 -4.0%
8.14
US$350,313 		43,036 -4.0% 8.14 US$350,313
2025-02-20 2025-02-20
US Pulmonx Corp (LUNG)
PrS Proposed sale
55,453
6.64
US$368,208 		55,453 6.64 US$368,208
2025-01-21 2025-01-17
US Pulmonx Corp (LUNG)
PlS Planned sale
2,221 -0.2%
6.50
US$14,436 		2,221 -0.2% 6.50 US$14,436
2025-01-17 2025-01-17
US Pulmonx Corp (LUNG)
PrS Proposed sale
2,221
6.40
US$14,214 		2,221 6.40 US$14,214
2025-01-21 2025-01-16
US Pulmonx Corp (LUNG)
PlS Planned sale
2,326 -0.2%
6.53
US$15,189 		2,326 -0.2% 6.53 US$15,189
2025-01-16 2025-01-16
US Pulmonx Corp (LUNG)
PrS Proposed sale
2,326
6.72
US$15,631 		2,326 6.72 US$15,631
2024-11-26 2024-11-22
US Pulmonx Corp (LUNG)
PlS Planned sale
20,000 -1.8%
6.63
US$132,600 		20,000 -1.8% 6.63 US$132,600
2024-11-22 2024-11-22
US Pulmonx Corp (LUNG)
PrS Proposed sale
20,000
6.42
US$128,400 		20,000 6.42 US$128,400
2024-10-21 2024-10-17
US Pulmonx Corp (LUNG)
PlS Planned sale
20,000 -1.8%
6.52
US$130,400 		20,000 -1.8% 6.52 US$130,400
2024-10-17 2024-10-17
US Pulmonx Corp (LUNG)
PrS Proposed sale
20,000
6.80
US$136,000 		20,000 6.80 US$136,000
2024-09-18 2024-09-12
US Pulmonx Corp (LUNG)
PlS Planned sale
20,000 -1.8%
8.09
US$161,800 		20,000 -1.8% 8.09 US$161,800
2024-09-12 2024-09-12
US Pulmonx Corp (LUNG)
PrS Proposed sale
20,000
7.75
US$155,000 		20,000 7.75 US$155,000
2024-03-05 2024-03-01
US Pulmonx Corp (LUNG)
S Sale
3,947 -0.4%
9.06
US$35,760 		3,947 -0.4% 9.06 US$35,760
2024-03-05 2024-03-01
US Pulmonx Corp (LUNG)
S Sale
1,818 -0.2%
9.06
US$16,471 		1,818 -0.2% 9.06 US$16,471
2024-03-05 2024-03-01
US Pulmonx Corp (LUNG)
PlS Planned sale
1,189 -0.1%
9.06
US$10,772 		1,189 -0.1% 9.06 US$10,772
2024-02-16 2024-02-15
US Pulmonx Corp (LUNG)
PlS Planned sale
20,000 -1.8%
14.60
US$292,000 		20,000 -1.8% 14.60 US$292,000
2024-02-15 2024-02-15
US Pulmonx Corp (LUNG)
PrS Proposed sale
20,000
14.60
US$292,016 		20,000 14.60 US$292,016
2024-01-22 2024-01-18
US Pulmonx Corp (LUNG)
PlS Planned sale
10,000 -0.9%
12.77
US$127,700 		10,000 -0.9% 12.77 US$127,700
2024-01-18 2024-01-18
US Pulmonx Corp (LUNG)
PrS Proposed sale
10,000
12.77
US$127,744 		10,000 12.77 US$127,744
2023-12-22 2023-12-21
US Pulmonx Corp (LUNG)
PlS Planned sale
10,000 -0.9%
12.42
US$124,200 		10,000 -0.9% 12.42 US$124,200
2023-12-21 2023-12-21
US Pulmonx Corp (LUNG)
PrS Proposed sale
10,000
12.42
US$124,171 		10,000 12.42 US$124,171
2023-12-05 2023-12-01
US Pulmonx Corp (LUNG)
S Sale
4,045 -0.3%
10.34
US$41,825 		4,045 -0.3% 10.34 US$41,825
2023-12-05 2023-12-01
US Pulmonx Corp (LUNG)
S Sale
1,591 -0.1%
10.34
US$16,451 		1,591 -0.1% 10.34 US$16,451
2023-12-05 2023-12-01
US Pulmonx Corp (LUNG)
S Sale
1,040 -0.1%
10.34
US$10,754 		1,040 -0.1% 10.34 US$10,754
2023-09-06 2023-09-01
US Pulmonx Corp (LUNG)
S Sale
3,921 -0.3%
10.01
US$39,249 		3,921 -0.3% 10.01 US$39,249
2023-09-06 2023-09-01
US Pulmonx Corp (LUNG)
S Sale
1,575 -0.1%
10.01
US$15,766 		1,575 -0.1% 10.01 US$15,766
2023-09-06 2023-09-01
US Pulmonx Corp (LUNG)
S Sale
1,031 -0.1%
10.01
US$10,320 		1,031 -0.1% 10.01 US$10,320
2023-07-24 2023-07-20
US Pulmonx Corp (LUNG)
PlS Planned sale
15,000 -1.3%
12.68
US$190,200 		15,000 -1.3% 12.68 US$190,200
2023-07-20 2023-07-20
US Pulmonx Corp (LUNG)
PrS Proposed sale
15,000
12.68
US$190,200 		15,000 12.68 US$190,200
2023-06-20 2023-06-15
US Pulmonx Corp (LUNG)
PlS Planned sale
10,000 -0.8%
12.68
US$126,800 		10,000 -0.8% 12.68 US$126,800
2023-06-15 2023-06-15
US Pulmonx Corp (LUNG)
PrS Proposed sale
10,000
12.68
US$126,800 		10,000 12.68 US$126,800
2023-06-02 2023-06-01
US Pulmonx Corp (LUNG)
S Sale
3,924 -0.3%
11.48
US$45,048 		3,924 -0.3% 11.48 US$45,048
2023-06-02 2023-06-01
US Pulmonx Corp (LUNG)
S Sale
1,577 -0.1%
11.48
US$18,104 		1,577 -0.1% 11.48 US$18,104
2023-06-02 2023-06-01
US Pulmonx Corp (LUNG)
S Sale
1,032 -0.1%
11.49
US$11,858 		1,032 -0.1% 11.49 US$11,858